Maturitas
Volume 57, Issue 4 , Pages 405-414, 20 August 2007

Black cohosh with or without St. John's wort for symptom-specific climacteric treatment—Results of a large-scale, controlled, observational study

  • Volker Briese

      Affiliations

    • Department of Gynecology at the Universitaets Klinikum Suedstadt, Suedring 81, D-18059 Rostock, Germany
  • ,
  • Ute Stammwitz

      Affiliations

    • Schaper & Brümmer GmbH & Co. KG, Bahnhofstrasse 35, D-38259 Salzgitter, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 5341 307520; fax: +49 5341 307524.
  • ,
  • Michael Friede

      Affiliations

    • Bardowickstrasse 34, D-28329 Bremen, Germany
  • ,
  • Hans-Heinrich Henneicke-von Zepelin

      Affiliations

    • Schaper & Brümmer GmbH & Co. KG, Bahnhofstrasse 35, D-38259 Salzgitter, Germany

Received 12 December 2006; received in revised form 25 April 2007; accepted 26 April 2007. published online 30 May 2007.

Abstract 

Objectives

To evaluate usage pattern, effectiveness and safety of Black cohosh alone or in fixed combination with St. John's wort on menopausal symptoms in general clinical practice.

Method

Prospective, controlled open-label observational study of 6141 women at 1287 outpatient gynecologists in Germany. Subjects were treated with recommended doses of study therapies, with treatment chosen by the participating physicians. Patients were followed up for 6 months, optionally 12 months. The primary effectiveness variable was Menopause Rating Scale (MRS) subscore PSYCHE at Month 3 evaluated by ANCOVA.

Results

The treatment groups were comparable at baseline, excepting the main MRS score and the PSYCHE score (monotherapy: 0.31±0.22; combination therapy: 0.42±0.23). Reductions from baseline were seen with both regimens for all variables. The changes in the primary variable remained significantly different between groups (p<0.001) when adjusted for differences at baseline with the combination therapy being superior: from 0.37 (adjusted) to 0.25 (95% CI: 0.24–0.25) and 0.23 (95% CI: 0.22–0.23) at Month 3 in the monotherapy and combination-therapy groups, respectively. The improvement by both therapies was maintained at 6 and 12 months. The rate of possibly treatment-related adverse events was 0.16%, all non-serious.

Conclusion

The results support the effectiveness and tolerability profiles of two Black cohosh-based therapies for menopausal symptoms in general practice. They were used differentially: the monotherapy for neurovegetative symptoms, the combination for patients with more pronounced mood complaints. The fixed combination of Black cohosh and St. John's wort was superior to Black cohosh alone in alleviating climacteric mood symptoms.

Keywords: Black cohosh, Cimicifuga racemosa, St. John's wort, Hypericum perforatum, Menopause, Phyto-therapy, Depressive mood swings, Treatment of climacteric symptoms, Controlled study

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(07)00165-X

doi:10.1016/j.maturitas.2007.04.008

Maturitas
Volume 57, Issue 4 , Pages 405-414, 20 August 2007